Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M40403 with Opioids for Cancer Pain
NCT00101621Phase 2Terminated
- Sponsor
- Metaphore Biotechnologies
- Start
- Aug 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of imisopasem manganese in cancer pain, sponsored by Metaphore Biotechnologies. Started Aug 2004; status: terminated.
02
Drugs
imisopasem manganese
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00101621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101621.